STERISHEALTHCAREPVTLTDADA8 Medicines
Jaipur 08048129013 boost@sterispharma.com
918955945010
Chat with us  

Chat with us on WhatsApp

×
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCAREPVTLTDADA8 65b0b7e3912bef38d51b547d Medicines https://www.sterispharma.com
Home Products PIOSTERIS 30
PIOSTERIS 30 Piogl
PIOSTERIS 30 Piogl
In Stock
Diabetic Range by Pioglitazone (30mg)

PIOSTERIS 30

INR 67 INR 95
You Save: INR 28 (29.47%) In Stock
COD available
Add to cart
Buy Now
COD available
Share with
Buy Now
Add to cart
Share this on :

Description

Product details

PIOSTERIS 30 Pioglitazone (30mg) Introduction: Type 2 diabetes mellitus (T2DM) presents a significant global health challenge, necessitating effective management strategies to mitigate its complications and improve patient outcomes. In recent years, Pioglitazone has emerged as a valuable therapeutic option for individuals with T2DM. PIOSTERIS 30, featuring Pioglitazone at a dosage of 30mg, represents a pivotal advancement in the armamentarium of antidiabetic medications. This article explores the features, efficacy, safety profile, and clinical implications of PIOSTERIS 30 in the management of T2DM. Understanding Pioglitazone: Pioglitazone belongs to the class of thiazolidinediones (TZDs), which exert their antidiabetic effects by improving insulin sensitivity in peripheral tissues such as adipose tissue, skeletal muscle, and liver. Through activation of peroxisome proliferator-activated receptor gamma (PPAR-γ) receptors, Pioglitazone enhances glucose uptake and utilization, leading to improved glycemic control in patients with T2DM. Key Features of PIOSTERIS 30: PIOSTERIS 30 is a pharmaceutical formulation containing Pioglitazone at a standardized dosage of 30mg per tablet. This dosage strength offers clinicians the flexibility to tailor treatment regimens to individual patient needs, ensuring optimal glycemic control. The formulation of PIOSTERIS 30 ensures consistency and reliability in dosing, facilitating effective diabetes management. Efficacy in Glycemic Control: Clinical studies have demonstrated the efficacy of Pioglitazone, including PIOSTERIS 30, in improving glycemic control in patients with T2DM. Pioglitazone has been shown to reduce hemoglobin A1c (HbA1c) levels, fasting plasma glucose, and postprandial glucose excursions, leading to improvements in overall glucose regulation. Additionally, Pioglitazone may offer benefits beyond glycemic control, including improvements in insulin sensitivity and lipid profiles. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 https://www.sterisonline.com/product/piosteris-30-134190

Keywords

  • Filter tags

Other Medicines

Related Medicines

MYCOAZITHER 250 Azithromycin (250mg) Introduction Azithromycin, marketed under the brand name MYCOAZITHER 250, is a widely used antibiotic that belongs to the macrolide class. It is effective against a broad spectrum of bacteria and is particularly noted for its use in treating respiratory, skin, and ear infections, as well as some sexually transmitted diseases. This article explores the use, mechanism, side effects, and other essential details of Azithromycin 250mg. What is MYCOAZITHER 250? MYCOAZITHER 250 refers to the 250mg dosage form of Azithromycin, an antibiotic that is favored for its once-daily dosing and short treatment courses compared to many other antibiotics. It is known for its effectiveness in treating various bacterial infections without the frequent dosing schedules required by other antibiotics. Mechanism of Action Azithromycin works by inhibiting protein synthesis in bacteria, thereby stopping their growth and multiplication. It binds to the 50S ribosomal subunit of the bacteria, which is crucial for bacterial survival. This action prevents bacteria from producing essential proteins needed for their growth, leading to their eventual death. Uses of MYCOAZITHER 250 MYCOAZITHER 250 is used to treat a range of bacterial infections including: Respiratory Infections: Such as bronchitis, pneumonia, and sinusitis. Skin Infections: Including impetigo, cellulitis, and folliculitis. Ear Infections: Particularly middle ear infections in children. Sexually Transmitted Diseases: Such as chlamydia and gonorrhea. Throat Infections: Including strep throat and tonsillitis. Dosage and Administration The dosage of MYCOAZITHER 250 typically depends on the type and severity of the infection: Respiratory, skin, and ear infections: Often a single dose of 500mg on the first day followed by 250mg daily for 4 more days. STDs like Chlamydia: A single dose of 1 gram (1000mg) may be prescribed. Patients are advised to take MYCOAZITHER 250 at least 1 hour before or 2 hours after meals to maximize absorption. Potential Side Effects While MYCOAZITHER 250 is generally well-tolerated, it can cause some side effects, including: Diarrhea or loose stools Nausea and vomiting Abdominal pain Headache Dizziness Rarely, more severe reactions like allergic reactions or liver problems Safety and Monitoring Patients with pre-existing liver disease, kidney issues, or those who are allergic to macrolide antibiotics should use MYCOAZITHER 250 with caution. Regular monitoring may be necessary for patients with severe underlying health conditions. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 https://www.sterisonline.com/product/mycoazither-250-134358
Buy Now
Add to cart
View Details
MYCOAZITHER 250

INR79

MOLNUPRIVE 200 Molnupiravir 200mg Introduction In the ongoing battle against the COVID-19 pandemic, MOLNUPRIVE 200, containing Molnupiravir 200mg, emerges as a significant antiviral medication. Initially developed for influenza, Molnupiravir has been repurposed and shows promising results in treating mild to moderate COVID-19 in non-hospitalized patients. This article will delve into the details of Molnupiravir 200mg, exploring its mechanism, uses, potential side effects, and other relevant clinical information. What is MOLNUPRIVE 200? MOLNUPRIVE 200 is the brand name for the oral antiviral drug Molnupiravir, formulated in 200mg capsules. It has gained emergency use authorization in various countries to treat COVID-19 and aims to reduce the risk of severe infection and hospitalization. Mechanism of Action Molnupiravir works by introducing errors into the viral RNA, effectively halting the virus's replication process. By mutating the genetic code of the SARS-CoV-2 virus, it prevents the virus from proliferating and spreading throughout the body. Indications for Use MOLNUPRIVE 200 is specifically indicated for: Adults with COVID-19: It is prescribed for patients who have tested positive for SARS-CoV-2, exhibit mild to moderate symptoms, and are at risk for developing severe illness, including hospitalization or death. Early Intervention: Best results are seen when administered within the first five days of symptom onset. Administration and Dosage The typical dosage of MOLNUPRIVE 200 involves: Taking four 200mg capsules, twice daily for five days. It should be taken as soon as possible after a diagnosis of COVID-19 and within the first five days of symptom onset. Potential Side Effects While MOLNUPRIVE 200 offers a beneficial treatment for COVID-19, potential side effects include: Diarrhea Nausea Dizziness Headaches It is crucial for patients to report any severe or persistent side effects to their healthcare provider. Precautions and Contraindications Molnupiravir is not recommended for: Pregnant Women: Due to potential risks to fetal development, it is not advised for use during pregnancy. Under 18 Years: Safety and efficacy have not been established in pediatric populations. Severe Renal Impairment: Adjustments in dosage or alternative treatments may be necessary. Clinical Studies and Effectiveness Clinical trials have shown that Molnupiravir can reduce the risk of hospitalization or death in patients with mild to moderate COVID-19 who are at risk for severe disease. However, it is less effective in patients already requiring hospitalization due to COVID-19. Conclusion MOLNUPRIVE 200 (Molnupiravir 200mg) represents a pivotal advancement in the treatment of COVID-19, particularly for early-stage patients at high risk of progression to severe disease. As the pandemic continues to evolve, medications like Molnupiravir play a crucial role in managing and mitigating its impact. Patients should consult their healthcare providers to understand the best use of this medication in their specific health scenarios. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 https://www.sterisonline.com/product/molnuprive-200-134019
Buy Now
Add to cart
View Details
MOLNUPRIVE 200

INR2520

MENEROPEN 500 IV Meropenem (500mg) Introduction Meropenem, marketed under the brand name MENEROPEN 500 IV, is a broad-spectrum antibiotic used to treat a variety of severe bacterial infections. This includes infections in the skin, lungs, stomach, and brain (such as meningitis). This article provides an in-depth analysis of Meropenem 500mg, discussing its uses, mechanism of action, potential side effects, and necessary precautions. What is MENEROPEN 500 IV? MENEROPEN 500 IV is an intravenous formulation of Meropenem, a carbapenem antibiotic. It is specifically dosed at 500mg for the treatment of complicated infections, where other antibiotics might not be effective. Meropenem is known for its ability to treat infections caused by a wide range of bacteria, including some that are resistant to other antibiotics. Mechanism of Action Meropenem works by interfering with the bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) which are essential for cell wall integrity in bacteria. By inhibiting these PBPs, Meropenem causes the cell wall to weaken and eventually rupture, leading to the death of the bacteria. Uses of MENEROPEN 500 IV MENEROPEN 500 IV is utilized in the treatment of several critical health conditions: Severe Pneumonia: Including hospital-acquired and ventilator-associated pneumonia. Complicated Urinary Tract Infections (UTIs): Including cases that are resistant to other antibiotics. Intra-abdominal Infections: Such as those arising from perforated appendicitis or bowel perforation. Meningitis: Effective in treating bacterial meningitis, an infection of the membranes covering the brain and spinal cord. Skin and Soft Tissue Infections: Especially those involving deeper layers of skin or produced by resistant bacteria. Administration Meropenem is administered intravenously, typically by a healthcare professional in a hospital setting. The frequency and duration of the treatment depend on the severity and type of infection being treated. Potential Side Effects While MENEROPEN 500 IV is a critical medication in the management of severe infections, it can cause side effects. These include: Gastrointestinal disturbances such as nausea and vomiting. Headache and dizziness. Potential allergic reactions, which could manifest as rashes, itching, or more severe reactions like anaphylaxis. Local reactions at the injection site, such as pain or inflammation. Rarely, it can affect blood cell counts and kidney function, which requires monitoring. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 https://www.sterisonline.com/product/meneropen-500-iv-133908
Buy Now
Add to cart
View Details
MENEROPEN 500 IV

INR529

Have any question or need any business consultation?

Contact Us

Have any question or need any business consultation?

Contact Us
Chat with us  

Customers

Opening Hours

    Subscribe Us

    Subscribe to our newsletter!
    Steris Pharma

    Social share